Prediction of risk of prolonged post-concussion symptoms: Derivation and validation of the TRICORDRR (Toronto Rehabilitation Institute Concussion Outcome Determination and Rehab Recommendations) score.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
07 2021
Historique:
received: 05 11 2020
accepted: 07 05 2021
entrez: 8 7 2021
pubmed: 9 7 2021
medline: 21 10 2021
Statut: epublish

Résumé

Approximately 10% to 20% of people with concussion experience prolonged post-concussion symptoms (PPCS). There is limited information identifying risk factors for PPCS in adult populations. This study aimed to derive a risk score for PPCS by determining which demographic factors, premorbid health conditions, and healthcare utilization patterns are associated with need for prolonged concussion care among a large cohort of adults with concussion. Data from a cohort study (Ontario Concussion Cohort study, 2008 to 2016; n = 1,330,336) including all adults with a concussion diagnosis by either primary care physician (ICD-9 code 850) or in emergency department (ICD-10 code S06) and 2 years of healthcare tracking postinjury (2008 to 2014, n = 587,057) were used in a retrospective analysis. Approximately 42.4% of the cohort was female, and adults between 18 and 30 years was the largest age group (31.0%). PPCS was defined as 2 or more specialist visits for concussion-related symptoms more than 6 months after injury index date. Approximately 13% (73,122) of the cohort had PPCS. Total cohort was divided into Derivation (2009 to 2013, n = 417,335) and Validation cohorts (2009 and 2014, n = 169,722) based upon injury index year. Variables selected a priori such as psychiatric disorders, migraines, sleep disorders, demographic factors, and pre-injury healthcare patterns were entered into multivariable logistic regression and CART modeling in the Derivation Cohort to calculate PPCS estimates and forward selection logistic regression model in the Validation Cohort. Variables with the highest probability of PPCS derived in the Derivation Cohort were: Age >61 years ([Formula: see text] = 0.54), bipolar disorder ([Formula: see text] = 0.52), high pre-injury primary care visits per year ([Formula: see text] = 0.46), personality disorders ([Formula: see text] = 0.45), and anxiety and depression ([Formula: see text] = 0.33). The area under the curve (AUC) was 0.79 for the derivation model, 0.79 for bootstrap internal validation of the Derivation Cohort, and 0.64 for the Validation model. A limitation of this study was ability to track healthcare usage only to healthcare providers that submit to Ontario Health Insurance Plan (OHIP); thus, some patients seeking treatment for prolonged symptoms may not be captured in this analysis. In this study, we observed that premorbid psychiatric conditions, pre-injury health system usage, and older age were associated with increased risk of a prolonged recovery from concussion. This risk score allows clinicians to calculate an individual's risk of requiring treatment more than 6 months post-concussion.

Sections du résumé

BACKGROUND
Approximately 10% to 20% of people with concussion experience prolonged post-concussion symptoms (PPCS). There is limited information identifying risk factors for PPCS in adult populations. This study aimed to derive a risk score for PPCS by determining which demographic factors, premorbid health conditions, and healthcare utilization patterns are associated with need for prolonged concussion care among a large cohort of adults with concussion.
METHODS AND FINDINGS
Data from a cohort study (Ontario Concussion Cohort study, 2008 to 2016; n = 1,330,336) including all adults with a concussion diagnosis by either primary care physician (ICD-9 code 850) or in emergency department (ICD-10 code S06) and 2 years of healthcare tracking postinjury (2008 to 2014, n = 587,057) were used in a retrospective analysis. Approximately 42.4% of the cohort was female, and adults between 18 and 30 years was the largest age group (31.0%). PPCS was defined as 2 or more specialist visits for concussion-related symptoms more than 6 months after injury index date. Approximately 13% (73,122) of the cohort had PPCS. Total cohort was divided into Derivation (2009 to 2013, n = 417,335) and Validation cohorts (2009 and 2014, n = 169,722) based upon injury index year. Variables selected a priori such as psychiatric disorders, migraines, sleep disorders, demographic factors, and pre-injury healthcare patterns were entered into multivariable logistic regression and CART modeling in the Derivation Cohort to calculate PPCS estimates and forward selection logistic regression model in the Validation Cohort. Variables with the highest probability of PPCS derived in the Derivation Cohort were: Age >61 years ([Formula: see text] = 0.54), bipolar disorder ([Formula: see text] = 0.52), high pre-injury primary care visits per year ([Formula: see text] = 0.46), personality disorders ([Formula: see text] = 0.45), and anxiety and depression ([Formula: see text] = 0.33). The area under the curve (AUC) was 0.79 for the derivation model, 0.79 for bootstrap internal validation of the Derivation Cohort, and 0.64 for the Validation model. A limitation of this study was ability to track healthcare usage only to healthcare providers that submit to Ontario Health Insurance Plan (OHIP); thus, some patients seeking treatment for prolonged symptoms may not be captured in this analysis.
CONCLUSIONS
In this study, we observed that premorbid psychiatric conditions, pre-injury health system usage, and older age were associated with increased risk of a prolonged recovery from concussion. This risk score allows clinicians to calculate an individual's risk of requiring treatment more than 6 months post-concussion.

Identifiants

pubmed: 34237056
doi: 10.1371/journal.pmed.1003652
pii: PMEDICINE-D-20-05392
pmc: PMC8266123
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003652

Déclaration de conflit d'intérêts

The authors have declared no competing interests.

Références

Brain Inj. 2015;29(2):228-37
pubmed: 25383595
J Neurotrauma. 2015 Apr 15;32(8):517-26
pubmed: 25222514
Am J Geriatr Psychiatry. 2014 Dec;22(12):1478-86
pubmed: 24315559
Sports Health. 2017 Jan/Feb;9(1):41-44
pubmed: 27697890
J Prim Care Community Health. 2015 Oct;6(4):264-78
pubmed: 26229059
Curr Opin Psychiatry. 2005 May;18(3):301-17
pubmed: 16639155
JAMA Pediatr. 2019 Jan 1;173(1):e183820
pubmed: 30398522
NeuroRehabilitation. 2011;29(4):317-29
pubmed: 22207058
JAMA. 2016 Mar 8;315(10):1014-25
pubmed: 26954410
Stat Med. 2004 May 30;23(10):1631-60
pubmed: 15122742
Br J Sports Med. 2013 Apr;47(5):250-8
pubmed: 23479479
Phys Sportsmed. 2009 Jun;37(2):141-59
pubmed: 20048521
Brain Inj. 2016;30(2):146-55
pubmed: 26618716
JAMA Psychiatry. 2019 Mar 1;76(3):249-258
pubmed: 30698636
Can J Neurol Sci. 2017 Jul;44(4):384-390
pubmed: 28162097
J Neurotrauma. 2017 Jan 1;34(1):31-37
pubmed: 27560623
J Pers Disord. 2012 Aug;26(4):524-38
pubmed: 22867504
CMAJ. 2018 Jul 23;190(29):E871-E882
pubmed: 30037888
Neuropsychology. 2012 May;26(3):304-13
pubmed: 22468823
Clin Neuropsychol. 2019 Aug;33(6):1016-1043
pubmed: 30618335
Arch Phys Med Rehabil. 2020 Jan;101(1):72-80
pubmed: 31562876
JAMA Neurol. 2019 Sep 1;76(9):1049-1059
pubmed: 31157856
J Neurotrauma. 2018 Nov 15;35(22):2691-2698
pubmed: 29690799
J Neurotrauma. 2010 Mar;27(3):527-39
pubmed: 19938945
Phys Sportsmed. 2016;44(1):20-8
pubmed: 26781686
J Rehabil Med. 2018 Dec 25;51(1):32-39
pubmed: 30426138
Ann Intern Med. 2012 Jun 5;156(11):767-75, W-261, W-262
pubmed: 22665814
J Head Trauma Rehabil. 2020 Jan/Feb;35(1):E60-E66
pubmed: 31246881
PLoS One. 2018 Aug 1;13(8):e0201348
pubmed: 30067844
Pain Res Manag. 2016;2016:2825856
pubmed: 27445604
Psychiatr Serv. 1999 Oct;50(10):1303-8
pubmed: 10506298
PLoS One. 2018 Apr 18;13(4):e0196062
pubmed: 29668716
Br J Sports Med. 2013 Apr;47(5):314-20
pubmed: 23479491
Br J Sports Med. 2017 Jun;51(12):941-948
pubmed: 28566342

Auteurs

Laura Kathleen Langer (LK)

KITE Research Institute at Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.

Seyed Mohammad Alavinia (SM)

KITE Research Institute at Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.
Faculty of Medicine, Division of Physical Medicine and Rehab, University of Toronto, Toronto, Canada.

David Wyndham Lawrence (DW)

Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.
Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Canada.
Mt Sinai Hospital, Toronto, Canada.

Sarah Elizabeth Patricia Munce (SEP)

KITE Research Institute at Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.
Department of Occupational Science & Occupational Therapy, University of Toronto, Toronto, Canada.
Rehabilitation Sciences Institute and Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada.

Alice Kam (A)

Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.

Alan Tam (A)

Faculty of Medicine, Division of Physical Medicine and Rehab, University of Toronto, Toronto, Canada.
Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.

Lesley Ruttan (L)

Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.
Graduate Department of Psychological Clinical Science, University of Toronto Scarborough, Toronto, Canada.

Paul Comper (P)

Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.
Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, Canada.
Rehabilitation Sciences Institute and Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Canada.

Mark Theodore Bayley (MT)

KITE Research Institute at Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.
Faculty of Medicine, Division of Physical Medicine and Rehab, University of Toronto, Toronto, Canada.
Toronto Rehabilitation Institute-University Health Network, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH